更昔洛韦治疗新生儿巨细胞病毒感染临床疗效分析  

Curative effect analysis of ganciclovir on cytomegalovirus infection in newborns

作　　者：苏文雁[1] 刘欣菊[1] 

机构地区：[1]山东莱芜莱芜市人民医院,271100

出　　处：《国际病毒学杂志》2013年第3期134-136,共3页International Journal of Virology

摘　　要：目的观察更昔洛韦治疗新生儿巨细胞病毒感染临床疗效，并总结治疗效果。方法收集2007年10月至2012年12月在山东省莱芜市人民医院就诊的巨细胞病毒感染患儿100例。应用更昔洛韦治疗，观察疗效。结果100例患儿中，治愈30例，症状好转56例，症状反复6例，放弃治疗8例。所有临床表现为肝功能损害的患儿经治疗后治愈或症状好转。分别有95．6％和95．0％临床表现为黄疸和支气管肺炎的患儿转归为治愈或症状好转。结论更昔洛韦对巨细胞病毒感染儿童的肺炎、肝功能损害、黄疸有较为显著的疗效。制定科学合理的护理策略是进一步提高患儿康复的重要保障。Objective To estimate the effect of ganciclovir in the treatment of infant cytomegalovir- us infection, and summarize the nursing strategy. Methods A total of 100 cases who were diagnosed as cy- tomegalovirus infection cases and received medical treatment in Laiwu City People＇ s Hospital from October 2007 to December 2012 were included in the study. The effectiveness of ganeiclovir in the treatment were ob- served. Results Of them, 30 were healed, 56 got better, 6 were relatpsed. 8 of them gave up the treat- ment. All the cases showed liver function damage, 95.6% with the symptom of jaundice, 95.0% with the symptom of bronchopneumonia were healed or got better after treatment. Conclusions Ganciclovir is effi- cient in treating the cytomegalovirus infection newborn with the symptoms of function damage, jaundice and pneumonia. Scientific nursing strategy is significant in improving the therapy effect.

关 键 词：巨细胞病毒感染 更昔洛韦 临床疗效 护理策略 

分 类 号：R722.1[医药卫生—儿科]